Physician profile
Kendra Coonse
NPI 1699181214
$16,518.30
in general payments reported to CMS, 2019-2025
20 companies · $252 in 2025
The $252 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $1,105 · 2021: $185 · 2022: $3,108 · 2023: $5,624 · 2024: $5,160 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,410 · Food and Beverage: $4,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,410.26 |
| Food and Beverage | $4,626.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,897.43 | 2022-2025 | Assurity, Optis, Mitraclip |
| Abiomed | $2,908.03 | 2021-2024 | Impella |
| Penumbra, INC. | $2,570.22 | 2024 | Indigo System, Penumbra System, Ruby Coil |
| Medtronic, INC. | $2,302.95 | 2022-2025 | Symplicity G3, Azure Xt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $1,535.97 | 2020-2025 | Watchman Flx, Watchman Access System, General - Vascular Access |
| Medtronic Vascular, INC. | $1,084.12 | 2019 | |
| Novartis Pharmaceuticals Corporation | $443.86 | 2022-2025 | |
| Inari Medical, INC. | $225.16 | 2022 | |
| Heartflow, INC. | $143.37 | 2022-2024 | |
| Shockwave Medical, INC | $124.40 | 2021-2025 | |
| Cvrx, INC. | $86.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $34.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $34.65 | 2022 | |
| Acist Medical Systems, INC. | $26.06 | 2024 | |
| Alnylam Pharmaceuticals INC. | $21.42 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $19.88 | 2023 | Lifesparc |
| Pfizer INC. | $16.13 | 2022 | |
| Teleflex LLC | $15.99 | 2023 | Vascband |
| Edwards Lifesciences Corporation | $15.31 | 2021 | |
| Lilly USA, LLC | $11.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Coonse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.